Subscribe
jarun011
jarun011 / iStockphoto.com
31 August 2017Americas

Bayer takes pre-emptive strike to protect haemophilia treatment

Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Jury orders Takeda subsidiary to pay Bayer $155 million
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Americas
US court rejects motion to dismiss Bayer haemophilia suit
16 March 2018   A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder.


Editor's picks

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

Editor's picks

Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025

More on this story

Americas
Jury orders Takeda subsidiary to pay Bayer $155 million
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Americas
US court rejects motion to dismiss Bayer haemophilia suit
16 March 2018   A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder.

More on this story

Americas
Jury orders Takeda subsidiary to pay Bayer $155 million
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Americas
US court rejects motion to dismiss Bayer haemophilia suit
16 March 2018   A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder.

More features

South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
In vivo cell therapy: A world beyond ex vivo engineering
Patent litigator with biotech and medical device background joins Sterlington
Resilience and the power of brands: Elisabeth Stewart-Bradley on 9/11, inclusion and the INTA presidency
Fenwick establishes new Boston office with trio of IP partners from Cooley
How pharma should prep for the six-bill avalanche from Congress
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
USPTO speeds up patent issuance amid widespread agency changes